Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CELU
stocks logo

CELU

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker
Wall Street analysts forecast CELU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELU is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CELU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELU is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.973
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 1.973
sliders
Low
6.00
Averages
6.00
High
6.00
no data image
No Data

Valuation Metrics

The current forward P/E ratio for Celularity Inc (CELU.O) is -0.47, compared to its 5-year average forward P/E of -3.42. For a more detailed relative valuation and DCF analysis to assess Celularity Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.42
Current PE
-0.47
Overvalued PE
0.51
Undervalued PE
-7.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.27
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.47
Undervalued EV/EBITDA
-6.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
20.66
Current PS
0.00
Overvalued PS
62.74
Undervalued PS
-21.42
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CELU News & Events

Events Timeline

(ET)
2025-10-30
08:17:56
Celularity and DefEYE Collaborate to Enhance Regenerative Treatments in Eye Care
select
2025-10-14 (ET)
2025-10-14
08:50:14
Celularity reveals release of Phase 2 study results for PDA-002
select
2025-09-03 (ET)
2025-09-03
08:06:36
Celularity Meets Nasdaq Listing Requirements Again
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.5
09-03Benzinga
Dow Drops More Than 1%; Nio Stock Declines Following Q2 Earnings Report

  • U.S. Stock Market Performance: U.S. stocks declined, with the Dow Jones falling over 1%, while the NASDAQ and S&P 500 also experienced significant drops. Notable movements included a 2% decrease in NIO shares following disappointing quarterly results, despite a year-over-year revenue increase.

  • Sector and Commodity Updates: Consumer staples saw a slight increase, while information technology stocks fell. In commodities, oil and gold prices rose, and European and Asian markets mostly closed lower, reflecting a broader trend of declining equities globally.

[object Object]
Preview
4.5
09-02Benzinga
Nasdaq Declines 1%; Signet Jewelers Reports Earnings Exceeding Expectations

  • U.S. Stock Market Performance: U.S. stocks opened lower, with the Nasdaq Composite down over 1%, while the Dow and S&P 500 also experienced declines. Notable movements included a 182% surge in HWH International Inc. shares and a 58% drop in CleanCore Solutions, Inc. shares.

  • Economic Indicators: The S&P Global manufacturing PMI showed a slight decrease to 53.0 in August, while U.S. construction spending fell by 0.1% month-over-month. The ISM manufacturing PMI rose to 48.7, but still fell short of market expectations.

[object Object]
Preview
4.0
08-18Benzinga
WBB Securities Begins Coverage of Celularity with a Speculative Buy Rating and Sets Price Target at $6

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing strategies and intelligence.

  • Market Winning Tool: Traders utilize Benzinga Pro's resources to enhance their trading success in the stock market.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Celularity Inc (CELU) stock price today?

The current price of CELU is 1.973 USD — it has decreased -2.33 % in the last trading day.

arrow icon

What is Celularity Inc (CELU)'s business?

Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.

arrow icon

What is the price predicton of CELU Stock?

Wall Street analysts forecast CELU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELU is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Celularity Inc (CELU)'s revenue for the last quarter?

Celularity Inc revenue for the last quarter amounts to 5.28M USD, decreased -43.16 % YoY.

arrow icon

What is Celularity Inc (CELU)'s earnings per share (EPS) for the last quarter?

Celularity Inc. EPS for the last quarter amounts to -0.88 USD, increased 20.55 % YoY.

arrow icon

What changes have occurred in the market's expectations for Celularity Inc (CELU)'s fundamentals?

The market is revising No Change the revenue expectations for CELU for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -18.13%.
arrow icon

How many employees does Celularity Inc (CELU). have?

Celularity Inc (CELU) has 123 emplpoyees as of December 05 2025.

arrow icon

What is Celularity Inc (CELU) market cap?

Today CELU has the market capitalization of 55.89M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free